Non classé
Progress in Liver and Bile Duct Cancer: New Insights from ESMO 2025
This year’s ESMO Congress showcased key advances in the treatment of liver and bile duct cancers. While some new immunotherapy combinations did n...
Advancing Patient-Centred Care at UEG Week 2025
UEG Week 2025 in Berlin provided a valuable chance to deepen collaboration with healthcare professionals, researchers, and patient advocates. The f...
EU HTA Has Begun: What New Joint Clinical Assessments Mean for Access to Digestive Cancer Medicines
From 12 January 2025, new oncology medicines will undergo EU-wide Joint Clinical Assessments (JCAs). This coordinated evaluation aims to accelerate...
Key Takeaways from ESMO GI 2025 on Pancreatic Cancer
Promising new therapies are emerging. Daraxonrasib, a KRAS-targeting pill, is in Phase 3 trials after earlier encouraging results and FDA Breakthro...
DiCE Grants — Autumn 2025
DiCE opens Autumn 2025 grants: unrestricted operational support for Full and Associate Members, plus the €5,000 Wolfram Nolte Memorial Award for ...
VOICE: A Life-Changing Training in Cancer Research
Patient advocates joined VOICE in London for a week of immersive learning at Barts Cancer Institute. Exploring cancer biology, research methods, an...
Promising Advances in Pancreatic Cancer: ASCO 2025 Highlights
Phase III PANOVA-3 trials show that Tumour-Treating Fields Improve Overall Survival Final data from the Phase 3 PANOVA-3 study of tumour treating f...
Amplifying the Patient Voice: Reflections from the WECAN Academy 2025
DiCE Patient Ambassador Mila Ogalla Toledo shares her experience at the WECAN Academy 2025 in Rome—a three-day training for cancer advocates acro...
AIDA Project Uses Artificial Intelligence to Improve Treatment for a Common Cause of Gastric Cancer
The AIDA project has developed an AI system that helps doctors choose more effective treatments for H. pylori, a major cause of gastric cancer. Bas...
A New Chapter for DiCE: Board Chair Shares Vision and Thanks
We welcome our new Board of Directors forming the core leadership of Digestive Cancers Europe. Their leadership will strengthen our mission. We tha...